Qiagen N.V. (QGEN) is a Healthcare company in the Diagnostics Research industry. It has a market capitalization of $9.02B, a trailing price-to-earnings ratio of 18.2 and a free-cash-flow yield of 4.9%. Over the most recent reported fiscal year, revenue grew 5.7% and free cash flow per share fell 11.1%.